Coustier Advisory

At Coustier Advisory, we help early-stage MedTech innovators confidently navigate the complex U.S. reimbursement landscape. Led by Nicole Coustier - with over 20 years of experience in U.S. Reimbursement and Market Access Design & Implementation. Nicole Coustier has led multi-year market access strategies that helped several breakthrough MedTech innovations—such as HeartFlow (valued at ~$1.5B+), Glaukos, Thoratec (acquired by St. Jude Medical for ~$3.4B), and Spiration (acquired by Olympus) and many more—through their early stages to achieve over 90% Reimbursement Coverage in the U.S, ultimately positioning them for acquisitions and IPOs. At Coustier Advisory, we provide strategic guidance to MedTech companies looking to: Build payer-aligned evidence from the start Understand the real-world coding and payment environment Accelerate traction with providers and payers Avoid costly missteps after FDA approval Reach commercial milestones and funding goals faster We don’t believe reimbursement should be a roadblock. With the right planning, it can become a strategic advantage. Whether you’re designing your pivotal trial, building a coverage strategy, validating your payment pathway, or preparing for investor diligence, we meet you where you are—and help you move forward, faster. Let’s make your innovation market-ready. Learn more at https://coustieradvisory.com